NASDAQ:MGTX
MeiraGTx Holdings Plc Stock News
$4.93
-0.0900 (-1.79%)
At Close: Apr 23, 2024
MeiraGTx Holdings PLC (MGTX) Reports Q4 Loss, Misses Revenue Estimates
10:46am, Thursday, 14'th Mar 2024
MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.47 per share versus the Zacks Consensus Estimate of a loss of $0.46. This compares to loss of $0.58 per share a year ago.
MeiraGTx (MGTX): Strong Industry, Solid Earnings Estimate Revisions
10:32am, Wednesday, 10'th Jan 2024
MeiraGTx (MGTX) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
MeiraGTx (MGTX) Stock Surges 35% in a Month: Here's Why
01:32pm, Tuesday, 02'nd Jan 2024
MeiraGTx's (MGTX) shares surge on the sale of rights for a rare ocular disease gene therapy for up to $ 415 million. This funding helps MGTX extend its cash runway into mid-2026.
Wall Street Analysts Believe MeiraGTx Holdings PLC (MGTX) Could Rally 221.78%: Here's is How to Trade
11:16am, Monday, 25'th Dec 2023
The average of price targets set by Wall Street analysts indicates a potential upside of 221.8% in MeiraGTx Holdings PLC (MGTX). While the effectiveness of this highly sought-after metric is questiona
MeiraGTx to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 21'st Nov 2023
LONDON and NEW YORK, Nov. 21, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph
MeiraGTx shares take off on $30M investment by Sanofi
11:43am, Monday, 30'th Oct 2023
MeiraGTx Holdings PLC (NASDAQ:MGTX) shares gained more than 25% after it announced Sanofi SA (ADR) (NYSE:SNY), a pharma giant best known for its vaccines, is purchasing 4 million of the gene company's
MeiraGTx shares jump as Sanofi invests in gene therapy
08:28am, Monday, 30'th Oct 2023
Shares of MeiraGTx Holdings PLC MGTX, -4.88% jumped 14% premarket on Monday after the gene therapy company announced that French drugmaker Sanofi SNY, -19.13% has made a $30 million investment.
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Misses Revenue Estimates
10:46am, Thursday, 10'th Aug 2023
MeiraGTx Holdings PLC (MGTX) came out with a quarterly loss of $0.53 per share versus the Zacks Consensus Estimate of a loss of $0.59. This compares to loss of $0.76 per share a year ago.
MeiraGTx Holdings PLC (MGTX) Soars 8.2%: Is Further Upside Left in the Stock?
05:23am, Thursday, 29'th Jun 2023
MeiraGTx Holdings PLC (MGTX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strengt
LONDON and NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced it will host a conference c
Does MeiraGTx Holdings PLC (MGTX) Have the Potential to Rally 320.9% as Wall Street Analysts Expect?
11:09am, Friday, 02'nd Jun 2023
The consensus price target hints at a 320.9% upside potential for MeiraGTx Holdings PLC (MGTX). While empirical research shows that this sought-after metric is hardly effective, an upward trend in ear
MeiraGTx to Participate in Upcoming Investor Conferences
05:00pm, Thursday, 20'th Apr 2023
LONDON and NEW YORK, April 20, 2023 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.
MeiraGTx to Present Clinical Data from Phase 1 Trial of AAV-hAQP1 for Radiation-Induced Xerostomia on Tuesday, December 13, 2022
04:30pm, Thursday, 08'th Dec 2022
LONDON and NEW YORK, Dec. 08, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ: MGTX), a vertically integrated, clinical stage gene therapy company, today announced it will host a conference
MeiraGTx to Participate in Upcoming Investor Conferences
04:30pm, Tuesday, 22'nd Nov 2022
LONDON and NEW YORK, Nov. 22, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph
MeiraGTx to Participate in Upcoming Investor Conferences
04:30pm, Thursday, 08'th Sep 2022
LONDON and NEW YORK, Sept. 08, 2022 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, P